"10.1371_journal.pone.0104512","plos one","2014-08-11T00:00:00Z","Richard M Gibson; Jan Weber; Dane Winner; Michael D Miller; Miguel E Qui√±ones-Mateu","University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America; Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic; Gilead Sciences, Inc., Foster City, California, United States of America; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America","Conceived and designed the experiments: MEQM. Performed the experiments: RMG JW DW. Analyzed the data: RMG JW MEQM. Contributed reagents/materials/analysis tools: MDM. Contributed to the writing of the manuscript: MEQM.","R.M.G. and M.E.Q.-M. developed the novel HIV-1 genotyping and coreceptor tropism assay, DEEPGEN HIV. M.D.M. is employed by Gilead Sciences, the developer of elvitegravir, which was used in this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","08","Richard M Gibson","RMG",5,TRUE,1,3,3,NA,TRUE,TRUE,FALSE,0,NA,FALSE
